You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Fifteen years after the Human Genome Project was declared completed, genomic medicine is beginning to be implemented, sooner than Green and others had expected.
During a webcast to discuss the recent funding announcement for genome centers, project organizers offered details on data generation and return of results.
The All of Us Participant Technology Systems Center offers web and mobile apps to aggregate data and engage patients who join the All of Us cohort program.
Although people have greater access to personalized drugs and tests than ever before, a survey by GenomeWeb and the PMC shows public awareness isn't improving.
Ahead of the national launch, 44,000 early participants signed up for the program during a beta phase, and 26,000 people have completed the enrollment process.
Trump has repeatedly threatened to drastically slash NIH funding, but its new $37 billion budget is a historic high.
Applicants will be expected to develop the capacity to conduct up to 200,000 genome-wide assays per year and generate high-quality genotyping and genome sequence data.
Following several Sync for Genes pilots, FHIR Genomics advocates are pushing for adoption of their standard to make omics data compatible with EHRs.
The Chinese government has implemented clearer regulatory guidance for genomic tests and invested in both clinical testing and research, spurring growth.
The health system has changed the way it offers patients pharmacogenomics and has mandated a new assessment in annual visits intended to identify patients eligible for other genetic tests.
Italy has held talks with vaccine developers to manufacture mRNA-based SARS-CoV-2 vaccines, according to the Financial Times.
The Associated Press reports US officials are removing restrictions on fetal tissue research that were added during the Trump Administration.
The Biden Administration is investing $1.7 billion to detect and monitor SARS-CoV-2 variants.
In PLOS this week: genome instability in Aicardi-Goutières Syndrome, introduction of SARS-CoV-2 to the Colombian Amazon, and more.